In the present study, we found that lymph node metastasis with positive lymph node ECS was the major determinant of OSCC outcomes (Table 3 and 4) and overexpression of cyclin D1 was significantly associated with lymph node metastasis (Table 2). The gene discussed is CCND1; the disease is metastatic malignant neoplasm in the lymph nodes.